In vitro efficacy of humanized regimen of flomoxef against extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Yamashiro, Hidenori; Kasamatsu, Yu; Anan, Naomi; Takemura, Miki; Yamano, Yoshinori

In vitro efficacy of humanized regimen of flomoxef against extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Yamashiro, Hidenori; Kasamatsu, Yu; Anan, Naomi; Takemura, Miki; Yamano, Yoshinori.

Afiliação

Yamashiro H; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd. , Toyonaka, Osaka, Japan.
Kasamatsu Y; Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine , Kyoto, Japan.
Anan N; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd. , Toyonaka, Osaka, Japan.
Takemura M; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd. , Toyonaka, Osaka, Japan.
Yamano Y; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd. , Toyonaka, Osaka, Japan.

Antimicrob Agents Chemother ; 67(9): e0025823, 2023 09 19.

Article em En | MEDLINE | ID: mdl-37610203

Assuntos

Cefmetazol; Cefoxitina; Klebsiella pneumoniae; Meropeném/farmacologia; Escherichia coli; Antibacterianos/farmacologia; Piperacilina; Tazobactam/farmacologia

Palavras-chave

antimicrobial; carbapenem sparing; extended-spectrum beta-lactamases; flomoxef; in vitro chemostat model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefmetazol / Cefoxitina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefmetazol / Cefoxitina Idioma: En Ano de publicação: 2023 Tipo de documento: Article